SBP solbec pharmaceuticals limited

That CancerVax(CNVX) failed phase 3 trial on melanoma caused the...

  1. skint
    3,630 Posts.
    lightbulb Created with Sketch. 116
    clock Created with Sketch.
    07/04/05
    15:50
    Post #: 862268
    That CancerVax(CNVX) failed phase 3 trial on melanoma caused the company to lose $US88 million market cap yesterday . Nice to be in a co like Solbec where the only question is not if it kills cancer , but which cancer does it kill best , for target selection in the upcomming phase 2 trials . Even with the failed trial CNVX market cap is 5 times Solbecs .
    Cheers
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.